abstract |
The present invention relates to a binding component, particularly an antibody molecule, to the alpha chain of the granulocyte macrophage colony stimulating factor receptor (GM-CSFR). The present invention also relates to the use of said binding component in the treatment of inflammatory and autoimmune diseases such as rheumatoid arthritis, asthma, allergic reactions, multiple sclerosis, myeloid leukemia, atherosclerosis and the like. |